On the stock market since 2021, it operates in the world of health and science. Now — the numbers.
This is an established company with proven profits.
An average decline of 100% a year over the last 3 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
If every debt were paid off today, $90.6M would still be left in the vault — a solid cushion for hard times.
The stock trades 19% below its peak. The market has trimmed its expectations for the company.
There is $96.6M in the vault; even if every debt were paid off, $90.6M would remain.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, BCYP sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: BCYP is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.